Hussman Strategic Advisors’s NeoGenomics NEO Stock Holding History

Hussman Strategic Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,250	Closed	-$425K	–	256
2023 Q4	$425K	Hold	26,250	–	–	0.1%	190
2023 Q3	$323K	Buy	+26,250	New	+$390K	0.06%	257
2020 Q3	–	Sell	-20,000	Closed	-$620K	–	292
2020 Q2	$620K	Sell	20,000 -5,000	-20%	-$139K	0.16%	199
2020 Q1	$690K	Hold	25,000	–	–	0.19%	194
2019 Q4	$731K	Sell	25,000 -75,000	-75%	-$1.79M	0.23%	151
2019 Q3	$1.91M	Hold	100,000	–	–	0.54%	72
2019 Q2	$2.19M	Sell	100,000 -100,000	-50%	-$2.19M	0.61%	67
2019 Q1	$4.09M	Hold	200,000	–	–	1%	11
2018 Q4	$2.52M	Hold	200,000	–	–	0.61%	59
2018 Q3	$3.07M	Buy	200,000 +50,000	+33%	+$691K	0.89%	29
2018 Q2	$1.97M	Buy	+150,000	New	+$1.65M	0.53%	85

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hussman Strategic Advisors's NEO Position: Q1 2024 in Review

Hussman Strategic Advisors sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 26,250 shares — an estimated $425K sold.

Hussman Strategic Advisors first reported a position in NEO in Q2 2018 and held it in 11 quarters. The position peaked at $4.09M in Q1 2019. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

Hussman Strategic Advisors reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
Hussman Strategic Advisors sold 26,250 NeoGenomics shares in Q1 2024, an estimated $425K.
Hussman Strategic Advisors first reported a position in NeoGenomics in Q2 2018 and held it in 11 quarters.
Hussman Strategic Advisors's NeoGenomics position peaked at $4.09M in Q1 2019.
263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Hussman Strategic Advisors's 13F filing for Q1 2024, filed 1 May 2024.